BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 19427685)

  • 1. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.
    Ozcan E; Garibyan L; Lee JJ; Bram RJ; Lam KP; Geha RS
    J Allergy Clin Immunol; 2009 Jun; 123(6):1277-86.e5. PubMed ID: 19427685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation.
    Castigli E; Wilson SA; Elkhal A; Ozcan E; Garibyan L; Geha RS
    J Allergy Clin Immunol; 2007 Oct; 120(4):885-91. PubMed ID: 17689597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation.
    Ozcan E; Rauter I; Garibyan L; Dillon SR; Geha RS
    J Allergy Clin Immunol; 2011 Sep; 128(3):601-9.e1-4. PubMed ID: 21741080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
    Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
    Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of TACI on NOD B cells results in germinal centre reaction anomalies, enhanced plasma cell differentiation and immunoglobulin production.
    Banday VS; Thyagarajan R; Sundström M; Lejon K
    Immunology; 2016 Nov; 149(3):297-305. PubMed ID: 27444337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.
    Kanswal S; Katsenelson N; Selvapandiyan A; Bram RJ; Akkoyunlu M
    J Immunol; 2008 Jul; 181(2):976-90. PubMed ID: 18606649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited expression of APRIL and its receptors prior to intestinal IgA plasma cell development during human infancy.
    Gustafson CE; Higbee D; Yeckes AR; Wilson CC; De Zoeten EF; Jedlicka P; Janoff EN
    Mucosal Immunol; 2014 May; 7(3):467-77. PubMed ID: 24045575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
    Lee JJ; Ozcan E; Rauter I; Geha RS
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency.
    Lee JJ; Jabara HH; Garibyan L; Rauter I; Sannikova T; Dillon SR; Bram R; Geha RS
    J Allergy Clin Immunol; 2010 Dec; 126(6):1234-41.e2. PubMed ID: 20889194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proliferation-inducing ligand sustains the proliferation of human naïve (CD27⁻) B cells and mediates their differentiation into long-lived plasma cells in vitro via transmembrane activator and calcium modulator and cyclophilin ligand interactor and B-cell mature antigen.
    Matsuda Y; Haneda M; Kadomatsu K; Kobayashi T
    Cell Immunol; 2015 Jun; 295(2):127-36. PubMed ID: 25880104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TACI regulates IgA production by APRIL in collaboration with HSPG.
    Sakurai D; Hase H; Kanno Y; Kojima H; Okumura K; Kobata T
    Blood; 2007 Apr; 109(7):2961-7. PubMed ID: 17119122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TACI-dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus.
    Tran NL; Schneider P; Santiago-Raber ML
    Eur J Immunol; 2017 Apr; 47(4):713-723. PubMed ID: 28267197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral-nasopharyngeal dendritic cells mediate T cell-independent IgA class switching on B-1 B cells.
    Kataoka K; Fujihashi K; Terao Y; Gilbert RS; Sekine S; Kobayashi R; Fukuyama Y; Kawabata S; Fujihashi K
    PLoS One; 2011; 6(9):e25396. PubMed ID: 21980444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
    Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C
    J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.
    Bossen C; Cachero TG; Tardivel A; Ingold K; Willen L; Dobles M; Scott ML; Maquelin A; Belnoue E; Siegrist CA; Chevrier S; Acha-Orbea H; Leung H; Mackay F; Tschopp J; Schneider P
    Blood; 2008 Feb; 111(3):1004-12. PubMed ID: 17942754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TACI is required for efficient plasma cell differentiation in response to T-independent type 2 antigens.
    Mantchev GT; Cortesão CS; Rebrovich M; Cascalho M; Bram RJ
    J Immunol; 2007 Aug; 179(4):2282-8. PubMed ID: 17675489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of BLyS/BLyS receptors in anti-chromatin B cell regulation.
    Hondowicz BD; Alexander ST; Quinn WJ; Pagán AJ; Metzgar MH; Cancro MP; Erikson J
    Int Immunol; 2007 Apr; 19(4):465-75. PubMed ID: 17369193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TACI expression and plasma cell differentiation are impaired in the absence of functional IκBNS.
    Khoenkhoen S; Erikson E; Ádori M; Stark JM; Scholz JL; Cancro MP; Pedersen GK; Karlsson Hedestam GB
    Immunol Cell Biol; 2019 May; 97(5):485-497. PubMed ID: 30597621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of Gut Secretory Immunoglobulin A in Memory B-Cell Dysfunction-Associated Disorders: A Possible Gut-Spleen Axis.
    Carsetti R; Di Sabatino A; Rosado MM; Cascioli S; Piano Mortari E; Milito C; Grimsholm O; Aranburu A; Giorda E; Tinozzi FP; Pulvirenti F; Donato G; Morini F; Bagolan P; Corazza GR; Quinti I
    Front Immunol; 2019; 10():2937. PubMed ID: 31969880
    [No Abstract]   [Full Text] [Related]  

  • 20. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells.
    Treml LS; Carlesso G; Hoek KL; Stadanlick JE; Kambayashi T; Bram RJ; Cancro MP; Khan WN
    J Immunol; 2007 Jun; 178(12):7531-9. PubMed ID: 17548587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.